Ezetimibe, Simvastatin Drug Combination
"Ezetimibe, Simvastatin Drug Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pharmaceutical preparation of ezetimibe and simvastatin that is used in the treatment of HYPERCHOLESTEROLEMIA and HYPERLIPIDEMIAS.
| Descriptor ID |
D000069499
|
| MeSH Number(s) |
D02.455.426.559.847.638.400.900.500 D03.383.082.301.550.500 D04.615.638.400.900.500 D26.310.431
|
| Concept/Terms |
Ezetimibe, Simvastatin Drug Combination- Ezetimibe, Simvastatin Drug Combination
- Ezetimibe-Simvastatin Combination
- Combination, Ezetimibe-Simvastatin
- Ezetimibe Simvastatin Combination
- Ezetimibe Simvastatin Drug Combination
- Ezetimibe-Simvastatin Drug Combination
- Combination, Ezetimibe-Simvastatin Drug
- Drug Combination, Ezetimibe-Simvastatin
|
Below are MeSH descriptors whose meaning is more general than "Ezetimibe, Simvastatin Drug Combination".
Below are MeSH descriptors whose meaning is more specific than "Ezetimibe, Simvastatin Drug Combination".
This graph shows the total number of publications written about "Ezetimibe, Simvastatin Drug Combination" by people in this website by year, and whether "Ezetimibe, Simvastatin Drug Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ezetimibe, Simvastatin Drug Combination" by people in Profiles.
-
Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes and hypercholesterolemia. Diabetes Care. 2010 May; 33(5):1021-4.
-
Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category. Metab Syndr Relat Disord. 2009 Dec; 7(6):601-10.
-
Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients. Curr Med Res Opin. 2006 Oct; 22(10):2041-53.
-
Striated muscle safety of ezetimibe/simvastatin (Vytorin). Am J Cardiol. 2006 Jan 15; 97(2):223-8.